ENVB | Enveric Biosciences, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.3350 - 0.3500
52 Week Range	0.2960 - 2.9200
Beta	1.82
Implied Volatility	387.37%
IV Rank	100.00%
Day's Volume	231,066
Average Volume	488,565
Shares Outstanding	10,388,700
Market Cap	3,506,186
Sector	Healthcare
Industry	Biotechnology
IPO Date	2015-05-04

Valuation
Profitability
Growth
Health
P/E Ratio	-0.14
Forward P/E Ratio	N/A
EPS	-2.42
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	7
Country	USA
Website	ENVB

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

ENVB's peers: ADPT, AKBA, ATNF, ATOS, AVIR, BNTX, CNSP, CYCCP, CYTO, DNA, ELEV, OCEA, HEPA, AVRO, CWBR, ZURA, EFTR, GERN, IMMP, IMMX, INO, LXRX, MRNA, NBTX, NBY, OCGN, ORMP, PALI, PDSB, PSTV, RIGL, RXRX, SLS, TNXP, VKTX, XBIO, CARM

*Chart delayed

Analyzing fundamentals for ENVB we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see ENVB Fundamentals page.

Watching at ENVB technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ENVB Technicals page.